A Clinical Tool for Reducing Central Nervous System Depression among Neonates Exposed to Codeine through Breast Milk

Prediction of Codeine Toxicity in Infants and Their Mothers Using a Novel Combination of Maternal Genetic Markers

(2012) J Sistonen et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Postpartum maternal codeine therapy and the risk of adverse neonatal outcomes: A retrospective cohort study

(2012) David N. Juurlink et al.   CLINICAL TOXICOLOGY

Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for Codeine Therapy in the Context of Cytochrome P450 2D6 (CYP2D6) Genotype

(2011) K R Crews et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Central Nervous System Depression of Neonates Breastfed by Mothers Receiving Oxycodone for Postpartum Analgesia

(2011) Jessica Lam et al.   JOURNAL OF PEDIATRICS

Codeine-acetaminophen versus nonsteroidal anti-inflammatory drugs in the treatment of post–abdominal surgery pain: a systematic review of randomized trials

(2009) Marieke Nauta et al.   AMERICAN JOURNAL OF SURGERY

Risk to the Breast-Fed Neonate From Codeine Treatment to the Mother: A Quantitative Mechanistic Modeling Study

(2009) S Willmann et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Genetic variation and response to morphine in cancer patients

(2008) Joy R. Ross et al.   CANCER

Pharmacogenetics of Neonatal Opioid Toxicity Following Maternal Use of Codeine During Breastfeeding: A Case–Control Study

(2008) P Madadi et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Pharmacogenetic insights into codeine analgesia: implications to pediatric codeine use

(2008) Parvaz Madadi et al.   PHARMACOGENOMICS